Home / Articles
THE JOURNAL / LAROZE PARTNERS
The Journal
of Leaders.
The Journal
of Leaders.
The Journal
of Leaders.
Market insights. A committed perspective.
Executive search, governance, succession, and compensation: our insights to inform the decisions of leaders, boards, and shareholders.
51 analyses to explore
Enter the log
FEATURED READING 01 / THE FIRM'S SELECTION
HEALTH, PHARMA & BIOTECH · OCT. 20, 2026
Recruiting a Healthcare CEO: How Long Does It Take, and How to Choose an Executive Search Firm
Recruiting a Healthcare CEO: How Long Does It Take, and How to Choose an Executive Search Firm
Recruiting a Healthcare CEO: How Long Does It Take, and How to Choose an Executive Search Firm
From defining the scope of the mandate to choosing the firm: key questions that shape a CEO search in healthcare.
By Thomas Rozier
Read the analysis
YOUR PERSPECTIVE
ANALYSIS / EDITORIAL ARCHIVE
Find the right lighting.
Find the right lighting.
Find the right lighting.
51 analyses
Tech & AI
Nearly two years after the European deadline, the French NIS 2 law has been postponed again. 52% of CISOs believe their scope is no longer entirely manageable.
Nearly two years after the European deadline, the French NIS 2 law has been postponed again. 52% of CISOs believe their scope is no longer entirely manageable.
Sam Lozinguez
Sam Lozinguez

Health, Pharma
Recruiting a Healthcare CEO: 8 to 361 Days According to Eight Public Cases, and Eight Questions to Choose an Executive Search Firm.
Recruiting a Healthcare CEO: 8 to 361 Days According to Eight Public Cases, and Eight Questions to Choose an Executive Search Firm.
Thomas Rozier
Thomas Rozier

Tech & AI
French Tech raised €8.7B in nine months, but Series B and C rounds are down 10%. This is the moment when a proven startup must become a true company and choose its CEO.
French Tech raised €8.7B in nine months, but Series B and C rounds are down 10%. This is the moment when a proven startup must become a true company and choose its CEO.
Sam Lozinguez
Sam Lozinguez

Health, Pharma
Recruiting a medtech CEO: Hologic, Masimo, Coloplast. The profile depends on the mission, from turnaround to integration. 2025 and 2026 figures.
Recruiting a medtech CEO: Hologic, Masimo, Coloplast. The profile depends on the mission, from turnaround to integration. 2025 and 2026 figures.
Thomas Rozier
Thomas Rozier

Tech & AI
Coding assistants and agents: the dominant use of AI among developers (Stack Overflow, October 6, 2026). What the board should ask their CTO before hiring them.
Coding assistants and agents: the dominant use of AI among developers (Stack Overflow, October 6, 2026). What the board should ask their CTO before hiring them.
Sam Lozinguez
Sam Lozinguez

Luxury, wines and spirits
Buying a Champagne house: Heidsieck & Co Monopole, EUR 50M, 92 days from signing to takeover. What a board decides before it appoints.
Buying a Champagne house: Heidsieck & Co Monopole, EUR 50M, 92 days from signing to takeover. What a board decides before it appoints.
Thomas Rozier
Thomas Rozier

Health, Pharma
Recruiting a biotech CEO: BioNTech, Idorsia, Sobi. 107 to 146 days to name a successor, the founder's role, mandate to be defined first.
Recruiting a biotech CEO: BioNTech, Idorsia, Sobi. 107 to 146 days to name a successor, the founder's role, mandate to be defined first.
Thomas Rozier
Thomas Rozier

Luxury, wines and spirits
57.1% of champagne bottles are exported. Markets, houses, career paths: what this demands of the head of a champagne house.
57.1% of champagne bottles are exported. Markets, houses, career paths: what this demands of the head of a champagne house.
Thomas Rozier
Thomas Rozier

Tech & AI
A public software CEO was worth $25M in 2012, a public AI CEO $26M in 2025, in constant dollars. The salary hasn't budged, equity makes up the total. What this requires of boards.
A public software CEO was worth $25M in 2012, a public AI CEO $26M in 2025, in constant dollars. The salary hasn't budged, equity makes up the total. What this requires of boards.
Sam Lozinguez
Sam Lozinguez
Luxury, wines and spirits
Pol Roger, Ayala, Telmont, TEVC, EPI: five champagne successions in 2026, four paths. What the choice of leader says about the shareholder.
Pol Roger, Ayala, Telmont, TEVC, EPI: five champagne successions in 2026, four paths. What the choice of leader says about the shareholder.
Thomas Rozier
Thomas Rozier

Retail
Italy and Romania sold, Argentina kept, three countries at 85% of revenue: what the Carrefour 2030 refocusing demands of executives.
Italy and Romania sold, Argentina kept, three countries at 85% of revenue: what the Carrefour 2030 refocusing demands of executives.
Thomas Rozier
Thomas Rozier

Retail
Fnac Darty and Casino: one reference shareholder, two governance frameworks. What this changes for the chief executive officer and the board.
Fnac Darty and Casino: one reference shareholder, two governance frameworks. What this changes for the chief executive officer and the board.
Thomas Rozier
Thomas Rozier

12
Showing 12 of 51 analyses
51
FROM READING TO DECISION
Does a topic resonate with your situation?
Does a topic resonate with your situation?
Let's take the conversation further regarding your next hire, executive succession, or compensation decision.
Talk in confidence ↗
